Ligand validation:5C1G

DA8: octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside

DA8 is a Ligand Of Interest in 5C1G designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5C1G_DA8_A_402	42%	43%	0.139	0.87	0.68	1.49	1	5	0	0	93%	0.931
2RJ7_DA8_A_452	82%	48%	0.078	0.944	1.15	0.88	-	1	0	0	93%	0.931
5C4D_DA8_A_402	74%	45%	0.093	0.936	1.16	0.98	3	2	0	0	93%	0.931
5C48_DA8_A_402	70%	47%	0.099	0.927	1.09	0.97	2	2	0	0	93%	0.931
5C38_DA8_A_403	68%	50%	0.101	0.925	0.89	1.03	1	2	0	0	93%	0.931
5C8R_DA8_A_402	66%	57%	0.11	0.928	0.82	0.82	1	1	0	0	93%	0.931
5C4C_DA8_A_403	66%	49%	0.109	0.926	0.91	1.04	1	3	0	0	93%	0.931

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.